10 th FRONTIERS IN IMMUNOLOGY RESEARCH INTERNATIONALCONFERENCE Island of Crete, Greece Minoa Palace Resort & Spa, July 1-4, 2017 SUBJECT CATEGORIES (scroll down) SCHEDULE OF MEETINGS & ACTIVITIES (scroll down) INSTRUCTIONS TO PROGRAM PARTICIPANTS (scroll down) PROGRAM, PRESENTATIONS, OBSERVERS (scroll down) SUBJECT CATEGORIES • Allergy and immunopathology • Antigen presentation • Autoimmunity • B cells • Cellular immunology • Cytokines, chemokines, inflammation • Dendritic cells • Diabetes • Imaging at the molecular, cellular or animal level • Immune responses to infectious diseases • Immunogenetics and gene discovery • Immunotherapy • Innate immunity • In silico modelling • Knockout and knock-in studies • Lymphocyte activation and homing • Lymphocyte differentiation and migration • Mechanisms of cell death • Molecular immunology • Mucosal immunology SIG • NK cells • NKT and T regulatory cells • Plasmon resonance • Protein crystallography • Science communication - BD award session • Signal transduction • Stem cells • T cell biology • The immune response to viral infections • The MHC and its interactions • Tolerance • Transplantation • Tumour immunology • Vaccine development • Veterinary immunology SIG
28
Embed
10th FRONTIERS IN IMMUNOLOGY RESEARCH ... - firnweb.com · Inform them that each presentation room will be equipped with flipchart and power point capability. ... vaccine against
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
10th FRONTIERS IN IMMUNOLOGY RESEARCH INTERNATIONALCONFERENCE
Island of Crete, Greece Minoa Palace Resort & Spa, July 1-4, 2017
SUBJECT CATEGORIES (scroll down)
SCHEDULE OF MEETINGS & ACTIVITIES (scroll down)
INSTRUCTIONS TO PROGRAM PARTICIPANTS (scroll down)
PROGRAM, PRESENTATIONS, OBSERVERS (scroll down)
SUBJECT CATEGORIES
• Allergy and immunopathology
• Antigen presentation
• Autoimmunity
• B cells
• Cellular immunology
• Cytokines, chemokines, inflammation
• Dendritic cells
• Diabetes
• Imaging at the molecular, cellular or animal level
• Immune responses to infectious diseases
• Immunogenetics and gene discovery
• Immunotherapy
• Innate immunity
• In silico modelling
• Knockout and knock-in studies
• Lymphocyte activation and homing
• Lymphocyte differentiation and migration
• Mechanisms of cell death
• Molecular immunology
• Mucosal immunology SIG
• NK cells
• NKT and T regulatory cells
• Plasmon resonance
• Protein crystallography
• Science communication - BD award session
• Signal transduction
• Stem cells
• T cell biology
• The immune response to viral infections
• The MHC and its interactions
• Tolerance
• Transplantation
• Tumour immunology
• Vaccine development
• Veterinary immunology SIG
10th Frontiers in immunology Research International Conference Island of Crete, Greece, June 30 – July 5, 2017
SCHEDULE OF MEETINGS & ACTIVITIES (subject to change) * *All excursions at extra cost
Friday, JUNE 30, 2017
Pre-Conference Day-Long Excursion: Knossos
Registration: 6 PM – 7 PM
Reception: 7:30 PM – 8:30 PM
Saturday, JULY 1, 2017
Registration: 8 AM – 2 PM
Sessions: 9 AM – 2 PM (lunch included)
Half-Day Excursion (after sessions): Chania Town
Sunday, JULY 2, 2017
Registration: 8 AM – 2 PM Sessions: 8:30 AM – 2 PM (lunch included)
Half-Day Excursion (after sessions): Falassarna
Monday, JULY 3, 2017
Registration: 8 AM – 2 PM Sessions: 8:30 AM – 2 PM (lunch included)
Half-Day Excursion (after sessions): Greek Night (Conference Hotel)
Tuesday, JULY 4, 2017
Registration: 8 AM – 12 Noon PM Sessions: 8:30 AM – 12 Noon
Half-Day Excursion (after sessions): Rethymno
Wednesday, JULY 5, 2017
Post-Conference Day-Long Excursion: Elafonisi
INSTRUCTIONS TO PROGRAM PARTICIPANTS
(a) ORAL PRESENTATIONS: Session Time Allocations: Most sessions are 135 minutes long each with three presenters; some sessions are 60 minutes long set up us as thematic brainstorming roundtables. Session Moderators: Assume overall responsibility for your session. Make an effort to contact the session participants before the meeting. Inform them that each presentation room will be equipped with flipchart and power point capability. Ask them if they have any special needs relating to their presentation and, in collaboration with the registration desk, try to satisfy those needs. Arrive at the session room 10 minutes in advance and make sure that it is in order and properly equipped. Welcome and introduce the participants. Start the session on time and adhere to the time schedule. Moderate the open discussion to the best of your ability. Presenters: Each presenter should take no more than 30 minutes and each; any remaining time should be devoted to questions from the audience. Stay within the allotted time of 30 minutes even though it may not be enough! Be well prepared. Please do not just read your paper. Your presentation of main points, methods, and conclusions should lead to a fruitful discussion during and after the session. Bring with you and make available five or more copies of your manuscript. Every presentation room will be equipped with screens, flipcharts and power point capability (computer and projector). For Power Point presentations, please feel free to bring your own equipment and all necessary cables and transformers required by standards in Greece. If the session's moderator is absent, the last presenter listed should take on the role of the moderator. (b) POSTER PRESENTATIONS:
• Displays and presentations have been scheduled to take place daily from 12 Noon to 1 PM Please search in the Program to find out when you present and be prepared to display prior to your presentation. After your presentation, please remove all materials that relate to your poster.
• Posters should be prepared on heavy paper (preferably laminated), plastic, foam or other that can readily be displayed and not exceed 3ft x 4ft (36 x 48 inches). Please note that FIRN would not provide any construction materials for, or electricity to, the posters.
• Posters should easily read from 2-3 feet away. Text should be limited to the core ideas and
presented in a font size that allows one to read it with ease. Experienced poster presenters suggest 3-6 graphics to mix in with your text to make the posters more engaging. Bring with you and make available five or more copies of your abstract and/or manuscript.
10th Frontiers in Immunology Research 2017 International Conference
1Fukuoka Children’s Hospital, 2Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Japan
Clarithromycin plus intravenous immunoglobulin therapy can reduce the relapse rate of Kawasaki Disease: a phase 2, open-label, randomized control study
(A roundtable is a brainstorming session open to all conference participants; it focuses on a pre-specified
theme based on one or more recent publications – see reference)
Reference: Maintenance of macrophage transcriptional programs and intestinal
homeostasis by epigenetic reader SP140 Stuti Mehta, et al., Science Immunology,
March 3, 2017: Vol. 2, Issue 9, DOI: 10.1126/sciimmunol.aag3160
MODERATOR:
Larry W. Kwak
Vice President and Cancer Center Associate Director, Translational Research & Developmental Therapeutics Director, Toni Stephenson Lymphoma Center
Dr. Michael Friedman Professor, Department of Hematology and Hematopoietic Stem Cell Transplantation City of Hope National Medical Center,
Beckman Research Institute, California, USA
Invited Roundtable Participants (in alphabetical order by last name):
Borros Arneth, Germany
Larry W. Kwak, USA
Becky M. Vonakis, USA
Uri Wormser, Israel
Yongliang Zhang, Singapore
Sunday, July 2, 2017, 12:45 Noon – 1:30 PM Session [7]: FIRN Conference Room Posters Area
POSTERS
Bevacizumab inhibits P-glycoprotein function in vitro and increases in vivo sorafenib concentrations in plasma of human colorectal carcinoma-bearing mice
Mahamadou Tandiaab, Chadi Abbaraac, Marie-Sophie Hudsonb, Dora Amora,
Mélanie Polrotd, Patrick Gonind, Laurence Bonhomme-Faivreab
a Laboratory of Pharmacology, Service Pharmacie, Hôpital Paul Brousse AP-HP, 14 avenue Paul-Vaillant Couturier,
94800 Villejuif, France b UPRES EA 4123, Faculty of Pharmaceutical Sciences, Université Paris-Sud XI, 5 rue Jean-Baptiste Clément,
92296 Châtenay-Malabry cedex, France c Department of Pharmacology and Toxicology,
Centre Hospitalier Universitaire d’Angers, 4 rue Larrey, 49100 Angers, France d Animal and Veterinary Resources,
IFR 54, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94800 Villejuif, France
The kinesin motor protein Kif7 is required
for T-cell development
Ching-In Lau1, Alessandro Barbarulo1, Anisha Solanki1, José Ignacio Saldaña1,2 and Tessa Crompton1
1 Immunobiology Section, UCL Great Ormond Street Institute of Child Health, London, UK
2 School of Health, Sport and Bioscience, University of East London, London, UK
The Pathogenesis of Interleukin-22 and Its Receptor
in UVB-induced Skin Inflammation
Yejin Kim1, Junmyung Lee1, Yejin Han1, Yeaseul Yoon1, Dasol Lee1, and Wang Jae Lee1,* and Jae Seung Kang1,*
1Laboratory of Vitamin C and Antioxidant Immunology, Department of Anatomy
and Cell Biology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Korea
Lunch: 1:30 – 2:30 PM (follow signs)
Sunday, July 2, 2017 Recommended Activity (after sessions):
FALASSARNA BEACH and out to dinner
Monday, July 3, 2017, 8:30 AM – 10:30 AM Session [8]: FIRN Conference Room Posters Area
MODERATOR:
Laurence Bonhomme-Faivre
Laboratory of Pharmacology, Service Pharmacie,
Hôpital Paul Brousse AP-HP, 14 avenue Paul-Vaillant Couturier, 94800 Villejuif, France &
UPRES EA 4123, Faculty of Pharmaceutical Sciences, Université Paris-Sud XI, 5 rue Jean-Baptiste Clément,
92296 Châtenay-Malabry cedex, France
Ethanol Alters the Balance of Sox2, Oct4 During Differentiation of Embryonic Stem Cells in Human Induced Pluripotent Stem
Cells (IPSC) Derived Neural Cells with an Inhibition of Neural Differentiation
Laurence Bonhomme-Faivre 1, Lucie Rivière 1,
Olivier Féraud 1,2, Thomas Lemonnier 4, Michel Reynaud 5 Annelise Bennaceur-Griscelli 1,2,3
1 INSERM UMR 935, SFR André Lwoff, University Paris Sud,
Paul Brousse Hospital, Villejuif, France APHP 2 Human Pluripotent Stem Cell Core Facility,
ESTeam Paris Sud, Villejuif France 3 National Infrastructure INGESTEM,
University Paris Sud, Inserm, Paris, France 4 INSERM UMRS 839 UMPC University Paris 06,
75005 Paris, France, Institut du Fer à Moulin. 5 AP-HP, Department of Psychiatry, University Hospitals
Paris Sud, Paul Brousse Hospital Villejuif, France.
A novel approach for cancer treatment
Uri Wormsera, Berta Brodskya, Yoram Finkelsteinb and Elena Proscuraa
aInstitute of Drug Research, School of Pharmacy,
Faculty of Medicine, The Hebrew University, Jerusalem, Israel bService and Unit of Neurology and Toxicology, Shaare Zedek Medical Center, Jerusalem, Israel
Differential Expression and Function of the TNF-Superfamily Members APRIL and BAFF and their Receptors
(BAFFR, BCMA, TACI) in Epithelial Tumors
V. Pelekanou1, K. Kalyvianaki1, V.I. Alexaki1, G. Notas1, M. Kampa1, E.N. Stathopoulos2, A. Tsapis3, E. Castanas1
Experimental Endocrinology (1), Pathology (2), School of Medicine,
University of Crete, Heraklion, Greece, and INSERM U976 Hopital St Louis, Paris, France (3)
Activin-A induces Hepatic stellate cell activation via the induction of TNFa και TGFβ in Kupffer cells
F. Kiagiadaki1, K. Kalyvianaki1, M. Kampa1,
E. Castanas1, E. Kouroumalis2, G. Notas1
Experimental Endocrinology (1) and Gastroenterology (2), School of Medicine, University of Crete, Heraklion, Greece
Cytotoxic B lymphocyte and plasmacytoid
dendritic cells in peripheral blood of patients with relapsing/remitting multiple sclerosis
Leonilda M.B. Santos, Vinicius Boldrini, Adriel S. Moraes, Verônica APG Silva, Ana Leda Longhini, Raphael
Quintiliano, Rafael P. Dias Carneiro, Charles P. Tilbery, Alfredo Damasceno, Benito P.Damasceno, Felipe von Glehn, Alessandro S. Farias and Carlos Otavio Brandão
Neuroimmunology Unit, Dept of Genetics, Evolution and Bioagents, Institute of Biology, UNICAMP,
Campinas, São Paulo, Brazil, Center for treatment of multiple sclerosis (CATEM) São Paulo, SP, Brazil
Coffee Break: 10:30 AM – 11:00 AM
Monday, July 3, 2017, 11:00 AM – 11:45 AM
Session [9]: FIRN Conference Room
FEATURED SPEAKER SESSION
MODERATOR:
Yongliang Zhang
Department of Molecular Microbiology and Immunology, Yong Loo Lin School of Medicine;
LSI Immunology Programme, the Life Science Institute, National University of Singapore
Targeting tumor-associated myeloid cells in human cancers
Larry W. Kwak
Vice President and Cancer Center Associate Director, Translational Research & Developmental Therapeutics Director, Toni Stephenson Lymphoma Center
Dr. Michael Friedman Professor, Department of Hematology and Hematopoietic Stem Cell Transplantation City of Hope National Medical Center, 1500 East Duarte Road,
Beckman Research Institute, Room 4117, Duarte CA 91010-3000, USA
Roundtable Session 3: Sp Transformer Proteins (A roundtable is a brainstorming session open to all conference participants; it focuses on a pre-specified
theme based on one or more recent publications – see reference)
Reference: Multitasking Immune Sp185/333 Protein, rSpTransformer-E1, and Its Recombinant
Fragments Undergo Secondary Structural Transformation upon Binding Targets Cheng Man Lun, et al., Journal of Immunology, February 27, 2017
DOI: https://doi.org/10.4049/jimmunol.1601795
MODERATOR:
Borros Arneth
Institute of Laboratory Medicine and Pathobiochemistry & Hospital of the Universities of Giessen and
Marburg Marburg, Germany
Invited Roundtable Participants (in alphabetical order by last name):
Borros Arneth, Germany
Maria Bicalho, Brazil
Amel Mahmoud Kamal Eldin, Egypt
Anisha Solanki, UK
Diana Yanez, UK
Lunch: 1:30 – 2:30 (follow signs)
Monday, July 3, 2017 Recommended Activity:
DINNER AT THE HOTEL & GREEK NIGHT Minoa Palace Resort & Spa
Tuesday, July 4, 2017, 8:30 AM – 10:30 AM Session [12]: FIRN Conference Room
MODERATOR:
Maria da Graça Bicalho
Laboratório de Imunogenética e
Histocompatibilidade, Departamento de Genética. Universidade Federal do Paraná.CEP 81 530-990 CP 19071
Curitiba, Paraná Brazil
The role of HLA-E polymorphisms in kidney transplantation success
Bruna Laís Mauricio de Miranda1; Geórgia Fernanda Gelmini1;
Matilde Risti1; José Samuel da Silva1; Valéria Sperandio Roxo1;
Maria Da Graça Bicalho1
1 Laboratório de Imunogenética e Histocompatibilidade (LIGH), Genetics Department, Universidade Federal do Paraná,
Curitiba, Brazil
Role of mitochondria-encoded subunit (NOX4) and prohibitin-1 in ovarian cancer
Amany A. Ghazy1, Nour M. El-Etreby2,
Radwaa Rashad3, Nermeen Mousa4
1 Department of Microbiology and Immunology, Faculty of Medicine, Kafrelskeikh University 2 Department of Obstetrics and Gynecology, Faculty of Medicine, Alexandria University
3 Department of Pathology, MedicalResearch Institute, Alexandria University 4 Department of Biotechnology, Institute of High Graduation, Alexandria University, Egypt
The Effect of Stem Cell and Niche on the Growth Inhibition of Mycobacterium Tuberculosis in Vitro Conditions
Müge KARAKAYALI1, Işıl AYDEMİR2, Pınar SÖNMEZ2,
Cengiz ÇAVUŞOĞLU3, İbrahim TUĞLU2
1Health Care Centre for students (Medico), Faculty of Medicine, University of Celal Bayar Manisa, Turkey
2Celal Bayar University Faculty of Medicine, Department of Histology and Embryology, Manisa, Turkey.
3 Ege University Faculty of Medicine, Department of Medical Microbiology, İzmir, Turkey
CD4+CD25-Foxp3+ T cells as a marker of disease activity and organ damage in systemic lupus erythematosus patients
Nermine N El-Maraghy1, Mona S. Ghaly2, Omar Dessouki3,
Samah Ismail Nasef2, Lobna Metwally1
1 Department of Microbiology and Immunology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt
2 Department of Rheumatology and Rehabilitation, Faculty of Medicine, Suez Canal University, Ismailia, Egypt
3 Department of Clinical Pathology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt
In search of the Criterion Standard Test in Diagnostic Testing
Thanos D. Kantarelis Managing Consultant, Navigant
Chicago, IL, USA &
Demetri Kantarelis Assumption College, Worcester, MA 01609, USA